EFFECTS OF 13 CIS-RETINOIC ACID ON GROWTH AND DIFFERENTIATION OF HUMAN FOLLICULAR CARCINOMA-CELLS (UCLA-R0-82-W-1) INVITRO

被引:96
作者
VANHERLE, AJ [1 ]
AGATEP, ML [1 ]
PADUA, DN [1 ]
TOTANES, TL [1 ]
CANLAPAN, DV [1 ]
VANHERLE, HML [1 ]
JUILLARD, GJF [1 ]
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIAT ONCOL, LOS ANGELES, CA 90024 USA
关键词
D O I
10.1210/jcem-71-3-755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dedifferentiation of human thyroid tumors is frequently found in humans. The effect of retinoids (13 cis-RA) was studied on the proliferation and differentiation of a human follicular cell line in vitro (UCLA RO 82 W-l). A significant and dose-dependent reduction (P < 0.001) in cell number and [3H] thymidine uptake was found in cells exposed to 13 cis-RA up to 10 μM. Higher concentrations of 13 cis-RA, however, led to a dose-dependent restoration of cell proliferation. Various parameters of differentiation increased under the influence of 13 cis-RA (10 μM) over nonexposed cells. The 125I uptake increased 4-fold over that in control nonexposed cells (P < 0.05). [12BI] Epidermal growth factor binding increased 5-fold, and [125I] human TSH binding increased significantly after exposure to 13 cis-RA (P < 0.02). Deiodinase activity, however, was significantly lower in 13 /cis-RA exposed cells than in control cells. The present study shows that 13 cis-RA (10 μM) drives the tumor cells toward a more normal state of proliferation and differentiation. © 1990 by The Endocrine Society.
引用
收藏
页码:755 / 763
页数:9
相关论文
共 39 条
[1]  
BACHRACH LK, 1985, PROGR ENDOCRINE RES, V2, P263
[2]  
BREITMAN TR, 1986, 1ST C DIFF THER, V5
[3]   I125 LABELED HUMAN EPIDERMAL GROWTH-FACTOR - BINDING, INTERNALIZATION, AND DEGRADATION IN HUMAN FIBROBLASTS [J].
CARPENTER, G ;
COHEN, S .
JOURNAL OF CELL BIOLOGY, 1976, 71 (01) :159-171
[4]  
CHOU JY, 1982, J CLIN ENDOCR METAB, V54, P1174, DOI 10.1210/jcem-54-6-1174
[5]   RETINOIDS ENHANCE MITOGENESIS BY TUMOR PROMOTOR AND POLYPEPTIDE GROWTH-FACTORS [J].
DICKER, P ;
ROZENGURT, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 91 (04) :1203-1210
[6]   THYROTROPIN RECEPTORS, TUMOR RADIOIODINE CONCENTRATION AND THYROGLOBULIN SECRETION IN DIFFERENTIATED THYROID CANCERS [J].
EDMONDS, CJ ;
KERMODE, JC .
BRITISH JOURNAL OF CANCER, 1985, 52 (04) :537-541
[7]  
EGGO MC, 1985, PROGR ENDOCRINE RES, V2, P201
[8]   CHARACTERIZATION OF A HUMAN FOLLICULAR THYROID-CARCINOMA CELL-LINE (UCLA-RO 82 W-1) [J].
ESTOUR, B ;
VANHERLE, AJ ;
JUILLARD, GJF ;
TOTANES, TL ;
SPARKES, RS ;
GIULIANO, AE ;
KLANDORF, H .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1989, 57 (03) :167-174
[9]   INDUCTION OF MORPHOLOGICAL AND FUNCTIONAL-DIFFERENTIATION OF HUMAN MYELOID-LEUKEMIA CELLS (HL-60 AND LK) BY A BENZOIC-ACID DERIVATIVE OF RETINOIC ACID [J].
FABIAN, I ;
SHVARTZMAYER, S ;
FIBACH, E .
LEUKEMIA RESEARCH, 1987, 11 (10) :863-868
[10]  
GOODMAN GE, 1982, CANCER RES, V42, P2087